Table 5.
Sample | Doxorubicin (μM) (72 h) | 5-FU (μM) (72 h) |
Etoposide (μM) (48 h) |
---|---|---|---|
HT29/mock | 0.59 ± 0.079 † | 0.92 ± 0.15 † | 67.85 ± 1.67 † |
HT29/ALDH1B1 | 1.073 ± 0.13 † | 1.79 ± 0.056 † | 92.47 ± 0.65 † |
Statistical significance | ** | *** | ** |
† Results are expressed as mean ± SD of three independent experiments. ** p < 0.01 and *** p < 0.001.